REG - GlaxoSmithKline PLC - Block listing Interim Review
RNS Number : 8829YGlaxoSmithKline PLC13 May 2019
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 13 May 2019
Name of applicant:
GlaxoSmithKline plc
Name of scheme:
GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan
Period of return:
From:
1 November 2018
To:
30 April 2019
Balance of unallotted securities under scheme(s) from previous return:
547,331
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
393,607
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
153,724
Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 13 May 2019
Name of applicant:
GlaxoSmithKline plc
Name of scheme:
GlaxoSmithKline Share Option Plan - Ordinary Shares
Period of return:
From:
1 November 2018
To:
30 April 2019
Balance of unallotted securities under scheme(s) from previous return:
2,223,352
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
958,344
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
1,265,008
Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 13 May 2019
Name of applicant:
GlaxoSmithKline plc
Name of scheme:
GlaxoSmithKline Share Option Plan - ADS
Period of return:
From:
1 November 2018
To:
30 April 2019
Balance of unallotted securities under scheme(s) from previous return:
7,336,096
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
1,424,800
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
5,911,296
Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 13 May 2019
Name of applicant:
GlaxoSmithKline plc
Name of scheme:
GlaxoSmithKline plc Share Save Plan 2012
Period of return:
From:
1 November 2018
To:
30 April 2019
Balance of unallotted securities under scheme(s) from previous return:
5,672,623
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
0
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
3,345,727
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
2,326,896
Name of contact:
Victoria Whyte
Telephone number of contact:
020 8047 5000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDBLRDMGMKVFMGLZM
Recent news on GSK
See all newsREG-GSK Plc: Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Transaction in Own Shares
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - Allianz Global Invs - Top 10 Holdings
AnnouncementREG - GSK PLC - Transaction in Own Shares
Announcement